Xeris Biopharma Holdings - 53 Year Dividend History | XERS
Historical dividend payout and yield for Xeris Biopharma Holdings (XERS) since 1971. The current TTM dividend payout for Xeris Biopharma Holdings (XERS) as of November 22, 2024 is $0.00. The current dividend yield for Xeris Biopharma Holdings as of November 22, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Drug Manufacturing |
$0.461B |
$0.164B |
|
Xeris Biopharma Holdings is a biopharmaceutical company. It involved in developing and commercializing therapies for patient in endocrinology, neurology and gastroenterology. The company's principal product includes Gvoke(R), a ready-to-use liquid glucagon for the treatment of severe hypoglycemia and Keveyis(R), the first and only FDA-approved therapy for primary periodic paralysis. Xeris Biopharma Holdings, formerly known as Xeris Pharmaceuticals Inc., is headquartered in Chicago, IL.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
